Conformation-Dependent Interactions Between HIV-1 Envelope Glycoproteins and Broadly Neutralizing Antibodies

被引:0
作者
Flemming, Juliana [1 ]
Wiesen, Lisa [1 ]
Herschhorn, Alon [1 ]
机构
[1] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Room 2-101 MRF,689 23rd Ave SE, Minneapolis, MN 55455 USA
关键词
HIV-1; entry; HIV-1 envelope glycoproteins; conformational transitions; broadly neutralizing antibodies; HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL-REGION; HUMAN MONOCLONAL-ANTIBODIES; GP120 INNER DOMAIN; CD4; BINDING-SITE; CD4-BOUND CONFORMATION; POTENT NEUTRALIZATION; GP41-GP120; INTERFACE; STRUCTURAL BASIS; TYPE-1; ENVELOPE;
D O I
10.1089/aid.2018.0102
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV type 1 (HIV-1) envelope glycoproteins (Env) mediate virus entry and are the target of neutralizing antibodies. Binding of the metastable HIV-1 Env trimer to the CD4 receptor triggers structural rearrangements that mediate Env conformational transitions from a closed conformation to a more open state through an intermediate step. Recent studies have revealed new insights on the dynamics, regulation, and molecular mechanisms of Env transitions along the entry pathway. In this study, we provide an overview of the current knowledge on Env conformational dynamics and the relationship between Env conformational states and neutralization selectivity of the broadly neutralizing antibodies that develop in 10%-20% of infected individuals and may provide guidance for the development of an effective HIV-1 vaccine.
引用
收藏
页码:794 / 803
页数:10
相关论文
共 50 条
  • [41] HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
    Dufloo, Jeremy
    Bruel, Timothee
    Schwartz, Olivier
    [J]. RETROVIROLOGY, 2018, 15
  • [42] HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies
    Serwanga, Jennifer
    Ssemwanga, Deogratius
    Muganga, Michael
    Nakiboneka, Ritah
    Nakubulwa, Susan
    Kiwuwa-Muyingo, Sylvia
    Morris, Lynn
    Redd, Andrew I.
    Quinn, Thomas C.
    Kaleebu, Pontiano
    [J]. VACCINE, 2018, 36 (04) : 578 - 586
  • [43] Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
    Malbec, Marine
    Porrot, Francoise
    Rua, Rejane
    Horwitz, Joshua
    Klein, Florian
    Halper-Stromberg, Ari
    Scheid, Johannes F.
    Eden, Caroline
    Mouquet, Hugo
    Nussenzweig, Michel C.
    Schwartz, Olivier
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (13) : 2813 - 2821
  • [44] Association Between HIV-1 Coreceptor Usage and Resistance to Broadly Neutralizing Antibodies
    Pfeifer, Nico
    Walter, Hauke
    Lengauer, Thomas
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (02) : 107 - 112
  • [45] Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies
    Verkoczy, Laurent
    Kelsoe, Garnett
    Moody, M. Anthony
    Haynes, Barton F.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (03) : 383 - 390
  • [46] Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers
    Sliepen, Kwinten
    Medina-Ramirez, Max
    Yasmeen, Anila
    Moore, John P.
    Klasse, Per Johan
    Sanders, Rogier W.
    [J]. VIROLOGY, 2015, 486 : 116 - 120
  • [47] Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
    Jardine, Joseph G.
    Sok, Devin
    Julien, Jean-Philippe
    Briney, Bryan
    Sarkar, Anita
    Liang, Chi-Hui
    Scherer, Erin A.
    Dunand, Carole J. Henry
    Adachi, Yumiko
    Diwanji, Devan
    Hsueh, Jessica
    Jones, Meaghan
    Kalyuzhniy, Oleksandr
    Kubitz, Michael
    Spencer, Skye
    Pauthner, Matthias
    Saye-Francisco, Karen L.
    Sesterhenn, Fabian
    Wilson, Patrick C.
    Galloway, Denise M.
    Stanfield, Robyn L.
    Wilson, Ian A.
    Burton, Dennis R.
    Schief, William R.
    [J]. PLOS PATHOGENS, 2016, 12 (08)
  • [48] Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller
    Freund, Natalia T.
    Wang, Haoqing
    Scharf, Louise
    Nogueira, Lilian
    Horwitz, Joshua A.
    Bar-On, Yotam
    Golijanin, Jovana
    Sievers, Stuart A.
    Sok, Devin
    Cai, Hui
    Lorenzi, Julio C. Cesar
    Halper-Stromberg, Ariel
    Toth, Ildiko
    Piechocka-Trocha, Alicja
    Gristick, Harry B.
    van Gils, Marit J.
    Sanders, Rogier W.
    Wang, Lai-Xi
    Seaman, Michael S.
    Burton, Dennis R.
    Gazumyan, Anna
    Walker, Bruce D.
    West, Anthony P., Jr.
    Bjorkman, Pamela J.
    Nussenzweig, Michel C.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (373)
  • [49] Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors
    Gonzalez, Nuria
    McKee, Krisha
    Lynch, Rebecca M.
    Georgiev, Ivelin S.
    Jimenez, Laura
    Grau, Eulalia
    Yuste, Eloisa
    Kwong, Peter D.
    Mascola, John R.
    Alcami, Jose
    [J]. PLOS ONE, 2018, 13 (03):
  • [50] Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope
    van Dorsten, Rebecca T.
    Lambson, Bronwen E.
    Wibmer, Constantinos Kurt
    Weinberg, Marc S.
    Moore, Penny L.
    Morris, Lynn
    [J]. JOURNAL OF VIROLOGY, 2020, 94 (02)